Compliance, patients, and retention for GLP-1 telehealth.
FDA has sent well over 100 warning letters to GLP-1 telehealth marketers since late 2025. Meta blocks drug-name ads, and Google wants LegitScript on every landing path. We built tools for exactly this, starting with a free scan of your site.
Request a free compliance scan-
Marketing compliance monitoring
Every page checked against the language FDA cited in its 2026 warning letters (brand equivalence, compounded products called FDA-approved, missing risk information) plus FTC endorsement rules. Quotes, context, and a fix for each item. From $299 a month after a free first scan.
-
State-routed patients from a holistic audience
Visitors arrive through organic search for holistic GLP-1 and peptide topics, pick their state and goal, and see your ongoing price before clicking. Per-lead or per-patient, priced below your blended acquisition cost.
-
A white-label retention layer
Nausea and muscle-preservation protocols, a source-cited concierge, supplement bundles, and check-in sequences under your brand. Supported patients stay past month four.
Our normalized daily price data is free to cite at /api/prices.